Mometasone (P medicine) 

Pharmacy Guides icon

Pharmacy guide

Mometasone furoate is licensed as a pharmacy (P) medicine and available over the counter (OTC) as Clarinaze Allergy Control 0.05% nasal spray.

As a pharmacist, you should be satisfied that the supply will be clinically suitable and used responsibly and appropriately in line with its marketing authorisation.

This pharmacy guide will help you to quickly and safely supply mometasone nasal spray OTC. It covers all the considerations before supply as well as a summary of the product information. However, it doesn’t cover the full list of contraindications or risk information. Further details can be found in the product’s individual Summary of Product Characteristics (SPC).

Updated: 26 July 2023

Sections on this page

  • Mometasone
  • Decision-making process for supply
  • Quantity to supply and repeat requests
  • Supply to the person’s representative
  • Counselling
  • Record keeping
  • Summary of product information
  • Hay fever and allergic rhinitis
  • Confidence in consultation skills
  • Further information

Become a Royal Pharmaceutical Society member to view this content.